CHECKMATE PHARMACEUTICALS IN - COM (CMPI)

CUSIP: 162818108

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COM
Total 13F shares
16,319,465
Share change
-361,849
Total reported value
$97,262,000
Price per share
$5.96
Number of holders
31
Value change
-$3,780,455
Number of buys
12
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 162818108?
CUSIP 162818108 identifies CMPI - CHECKMATE PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CHECKMATE PHARMACEUTICALS IN - COM (CMPI) as of Q2 2021

As of 30 Jun 2021, CHECKMATE PHARMACEUTICALS IN - COM (CMPI) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,319,465 shares. The largest 10 holders included venBio Partners LLC, Sofinnova Investments, Inc., Novo Holdings A/S, Clough Capital Partners L P, Medicxi Ventures Management (Jersey) Ltd, Omega Fund Management, LLC, FMR LLC, Sectoral Asset Management Inc, VANGUARD GROUP INC, and DEUTSCHE BANK AG\. This page lists 31 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.